What is Guillain-Barré Syndrome (GBS)? Understanding Symptoms, Causes, and Types

Guillain-Barré Syndrome (GBS) is a rare but serious autoimmune disorder where the body’s immune system mistakenly attacks the peripheral nerves. This attack damages the nerves, often leading to muscle weakness, numbness, and in severe cases, paralysis. Understanding What Is Gbs is crucial for early diagnosis and treatment, which can significantly improve outcomes.

Nerve and Damaged Myelin Sheath

The hallmark of the demyelinating form of Guillain-Barré Syndrome is the destruction of the myelin sheath. This protective covering around peripheral nerves is vital for efficient nerve signal transmission. When GBS damages the myelin sheath, it disrupts the nerves’ ability to send signals to the brain effectively. This disruption is what leads to the characteristic symptoms of GBS.

Initially, individuals with GBS typically experience tingling sensations and weakness, often starting in the hands and feet. These symptoms can progress rapidly, spreading throughout the body and potentially leading to paralysis. In its most acute form, Guillain-Barré Syndrome is considered a medical emergency, requiring immediate hospitalization and treatment. While GBS can be life-threatening in severe cases, most individuals recover, although the recovery process can be lengthy and may involve lasting effects.

Guillain-Barré Syndrome is not a common condition, and its precise cause remains unknown. However, research indicates that approximately two-thirds of individuals who develop GBS experience symptoms of an infection in the weeks preceding the onset of neurological symptoms. These preceding infections are often respiratory or gastrointestinal illnesses, and have been linked to conditions like COVID-19 and Zika virus.

Currently, there is no known cure for Guillain-Barré Syndrome. Treatment strategies focus on managing symptoms, reducing the severity of the immune system’s attack, and supporting the body during recovery. While the recovery timeline can vary significantly, potentially taking several years for full recuperation, the majority of people with GBS regain their ability to walk within six months of symptom onset. Despite generally positive outcomes, some individuals may experience residual effects, including persistent weakness, numbness, or chronic fatigue.

Symptoms of Guillain-Barré Syndrome

The progression of Guillain-Barré Syndrome symptoms often follows a characteristic pattern, typically beginning with tingling and weakness in the extremities, particularly the feet and legs. This sensation then ascends, spreading to the upper body and arms. It’s important to note that in some cases, the initial symptoms may manifest in the arms or face. As GBS advances, muscle weakness can intensify, culminating in paralysis.

Common symptoms associated with Guillain-Barré Syndrome include:

• Paresthesia: A “pins and needles” sensation experienced in the fingers, toes, ankles, or wrists, often as an initial symptom.
• Ascending Weakness: Muscle weakness that begins in the legs and progressively spreads upwards to the upper body.
• Gait and Mobility Issues: An unsteady gait, difficulty walking, or inability to walk or climb stairs due to muscle weakness.
• Cranial Nerve Dysfunction: Challenges with facial movements, such as speaking, chewing, or swallowing, indicating involvement of cranial nerves.
• Ocular Motor Weakness: Double vision or difficulty moving the eyes, suggesting nerve involvement affecting eye muscles.
• Severe Pain: Pain described as achy, shooting, or cramp-like, which can be intense and may worsen at night. This neuropathic pain is a significant symptom for some individuals.
• Autonomic Dysfunction: Problems with bladder control or bowel function, reflecting the impact on the autonomic nervous system.
• Cardiovascular Instability: Rapid heart rate, low or high blood pressure, indicating autonomic nervous system dysregulation.
• Respiratory Distress: Difficulty breathing, which can become a critical complication as weakness affects respiratory muscles.

The peak of muscle weakness in Guillain-Barré Syndrome is typically reached within the first two weeks after symptoms emerge. This rapid progression underscores the importance of prompt medical attention if GBS is suspected.

Types of Guillain-Barré Syndrome

The clinical presentation of Guillain-Barré Syndrome can vary, leading to the classification of several subtypes. These subtypes differ in their geographical prevalence and specific symptom patterns. The main types of GBS are:

• Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP): This is the most prevalent form of GBS, particularly in North America and Europe. AIDP is characterized by muscle weakness that begins in the lower body and ascends upwards. The demyelinating nature of AIDP involves damage to the myelin sheath of peripheral nerves.
• Miller Fisher Syndrome (MFS): In Miller Fisher Syndrome, paralysis characteristically begins in the eyes, manifesting as ophthalmoplegia (weakness of eye muscles). MFS is also frequently associated with ataxia, resulting in an unsteady gait. While less common in the United States, MFS is observed more frequently in Asian populations.
• Acute Motor Axonal Neuropathy (AMAN) and Acute Motor-Sensory Axonal Neuropathy (AMSAN): These axonal forms of GBS are less common in the U.S. but are more prevalent in regions such as China, Japan, and Mexico. AMAN primarily affects motor nerves, while AMSAN involves both motor and sensory nerves. These subtypes involve axonal damage, directly affecting the nerve fibers themselves, rather than primarily the myelin sheath.

Understanding these different types of Guillain-Barré Syndrome is important for diagnosis and management, as they may present with slightly different clinical features and potentially have varying prognoses.

When to Seek Immediate Medical Attention

Prompt medical evaluation is crucial for individuals experiencing symptoms suggestive of Guillain-Barré Syndrome. While mild tingling in the fingers or toes that is not progressing may not necessitate emergency care, certain symptoms warrant immediate medical attention.

Seek emergency medical help if you experience any of the following serious symptoms:

• Ascending Tingling: Tingling sensations that started in the feet or toes and are now moving upwards into the body. This indicates a progression of potential nerve involvement.
• Rapidly Spreading Weakness: Tingling or weakness that is spreading quickly throughout the body. This rapid progression is a hallmark of GBS and requires urgent assessment.
• Respiratory Difficulty: Trouble catching your breath or shortness of breath, especially when lying flat. This suggests potential weakness of respiratory muscles, a life-threatening complication.
• Swallowing Difficulty: Choking on saliva or experiencing difficulty swallowing. This can indicate cranial nerve involvement and potential airway compromise.

Guillain-Barré Syndrome is a serious condition that can worsen rapidly, making immediate hospitalization necessary. Early treatment initiation is associated with a better chance of complete recovery and reducing the risk of long-term complications. If you suspect you or someone you know may have GBS, do not hesitate to seek emergency medical care.

Causes of Guillain-Barré Syndrome

The exact etiology of Guillain-Barré Syndrome remains elusive. However, it is widely recognized as an immune-mediated disorder, often occurring following an infection. In most cases, GBS manifests days or weeks after a respiratory or digestive tract infection. Less frequently, surgical procedures or vaccinations have been identified as potential triggers for GBS.

In Guillain-Barré Syndrome, the body’s immune system, which normally targets foreign pathogens, aberrantly begins to attack the peripheral nerves. In the most common form, AIDP, this immune attack primarily targets the myelin sheath, the protective covering of the nerves. Damage to the myelin sheath disrupts the nerve’s ability to conduct electrical signals effectively to the brain. This impaired nerve signal transmission results in the characteristic symptoms of weakness, numbness, and paralysis associated with GBS.

Several infections and other factors have been implicated as potential triggers for Guillain-Barré Syndrome:

• Campylobacter Infection: The most frequently identified trigger is infection with Campylobacter jejuni, a bacterium commonly found in undercooked poultry and a common cause of diarrheal illness.
• Viral Infections: Various viruses have been associated with GBS, including:
  • Influenza virus (flu).
  • Cytomegalovirus (CMV).
  • Epstein-Barr virus (EBV), the cause of mononucleosis.
  • Zika virus.
  • Hepatitis viruses (A, B, C, and E).
  • HIV (human immunodeficiency virus).
• Mycoplasma pneumoniae: Infection with Mycoplasma pneumoniae, a bacterium that can cause pneumonia.
• Surgery and Trauma: Surgical procedures and physical trauma have been reported as less common triggers.
• Hodgkin Lymphoma: This type of cancer has been associated with an increased risk of GBS.
• Vaccinations (Rarely): In rare instances, influenza vaccines and childhood vaccinations have been temporally associated with GBS, although the causal link is not definitively established and the risk is considered extremely low.
• COVID-19 Virus: Infection with the SARS-CoV-2 virus (COVID-19) has been identified as a trigger for GBS in some individuals.

While these factors are associated with an increased risk of GBS, it is important to emphasize that Guillain-Barré Syndrome remains a rare complication, even following these potential triggers. The precise mechanisms by which these triggers lead to the autoimmune nerve attack in GBS are still under investigation.

Risk Factors for Guillain-Barré Syndrome

Guillain-Barré Syndrome can affect individuals across all age groups. However, the risk of developing GBS increases with age. Furthermore, GBS is observed slightly more frequently in males compared to females.

While age and sex are recognized risk factors, it is crucial to remember that Guillain-Barré Syndrome is not predictable and can occur in anyone, regardless of their demographic profile. The underlying reasons for the increased risk with age and male sex are not fully understood and are areas of ongoing research.

Complications of Guillain-Barré Syndrome

Guillain-Barré Syndrome can lead to a range of complications due to its impact on nerve function, which controls movement and various bodily functions. These complications can be serious and require careful medical management.

Potential complications of Guillain-Barré Syndrome include:

• Respiratory Failure: Weakness or paralysis can extend to the muscles responsible for breathing, potentially leading to respiratory failure. This is a life-threatening complication, and a significant proportion of GBS patients (up to 22%) require temporary mechanical ventilation within the first week of hospitalization.
• Residual Sensory or Motor Deficits: While most individuals with GBS achieve substantial recovery, some may experience persistent residual effects. These can include minor weakness, numbness, or tingling sensations that linger even after recovery.
• Cardiovascular Instability: Fluctuations in blood pressure and the development of irregular heart rhythms (cardiac arrhythmias) are common autonomic nervous system complications in GBS. These cardiovascular issues require careful monitoring and management.
• Pain: A significant proportion of GBS patients (approximately one-third) experience neuropathic pain. This nerve pain can be challenging to manage and may require specific pain medications.
• Bowel and Bladder Dysfunction: Sluggish bowel function (constipation) and urinary retention (difficulty emptying the bladder) can occur due to autonomic nerve involvement in GBS.
• Blood Clots (Deep Vein Thrombosis – DVT): Immobility associated with GBS-related paralysis increases the risk of developing blood clots, particularly in the deep veins of the legs. Preventative measures, such as blood thinners and support stockings, are often necessary until mobility is restored.
• Pressure Sores (Bedsores): Prolonged immobility can also lead to the development of pressure sores. Frequent repositioning and meticulous skin care are essential to prevent these sores.
• Relapse: Although uncommon, a small percentage of individuals with Guillain-Barré Syndrome may experience a relapse of symptoms. Relapses can occur even years after the initial episode and can manifest as recurrent muscle weakness.
• Mortality: In rare cases, Guillain-Barré Syndrome can be fatal. Death is usually attributed to severe complications such as respiratory distress syndrome, cardiac arrest, or other life-threatening complications.

The risk of serious long-term complications and mortality is higher when the initial symptoms of Guillain-Barré Syndrome are severe and rapidly progressive. Therefore, early diagnosis, prompt treatment, and vigilant monitoring for potential complications are paramount in managing GBS and improving patient outcomes.

By Mayo Clinic Staff

Guillain-Barre syndrome care at Mayo Clinic

Request an appointment

Diagnosis & treatment

June 07, 2024

Print

References:

1. Shahrizaila N, et al. Guillain-Barre syndrome. The Lancet. 2021; doi:10.1016/S0140-6736(21)00517-1.
2. Yao J, et al. Progress in Guillain-Barre syndrome immunotherapy — A narrative review of new strategies in recent years. Human Vaccines & Immunotherapeutics. 2023; doi:10.1080/21645515.2023.2215153.
3. Guillain-Barre. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/guillain-barre-syndrome. Accessed March 22, 2024.
4. Ferri FF. Guillain-Barre syndrome. In: Ferri’s Clinical Advisor 2024. Elsevier; 2024. https://www.clinicalkey.com. Accessed March 22, 2024.
5. Edwards KM, et al. COVID-19: Vaccines. https://www.uptodate.com/contents/search. Accessed March 25, 2024.
6. Loscalzo J, et al., eds. Guillain-Barre syndrome and other immune-mediated neuropathies. In: Harrison’s Principles of Internal Medicine. 21st ed. McGraw Hill; 2022. https://accessmedicine.mhmedical.com. Accessed March 22, 2024.
7. Muley SA. Guillain-Barre syndrome in adults: Treatment and prognosis. https://www.uptodate.com/contents/search. Accessed March 22, 2024.
8. You E. Guillain-Barre syndrome in children: Treatment and prognosis. https://www.uptodate.com/contents/search. Accessed March 22, 2024.
9. Ami TR. Allscripts EPSi. Mayo Clinic. March 22, 2024.
10. Leonhard SE, et al. Diagnosis and management of Guillain-Barre syndrome in ten steps. Nature Reviews Neurology. 2019; doi:10.1038/s41582-019-0250-9.
11. Guillain-Barre syndrome. Merck Manual Professional Version. https://www.merckmanuals.com/professional/neurologic-disorders/peripheral-nervous-system-and-motor-unit-disorders/guillain-barr%C3%A9-syndrome-gbs. Accessed March 22, 2024.